Detalhe da pesquisa
1.
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.
Clin Infect Dis
; 58(9): 1219-26, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550378